Sheba Medical Center — Ramat Gan

Public research footprint of Sheba Medical Center, compiled from the ClinicalTrials.gov public registry.

1,442

Registered studies

494

Active

268

Recruiting now

566

Completed

159

Stopped or withdrawn

Most-studied conditions

Crohn Disease · HR Low-Positive/HER2-Negative Breast Neoplasms · Von Hippel-Lindau Disease · Triple Negative Breast Neoplasms

Recently updated registry entries

NCT07015983 — A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in… (Active Not Recruiting)
NCT04924075 — Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… (Recruiting)
NCT03725007 — A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sheba Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.